PPARγ Agonists: Blood Pressure and Edema
Peroxisome proliferator activated receptor γ (PPARγ) agonists are widely used in the treatment of type 2 diabetes. Side effects of drug treatment include both fluid retention and a lowering of blood pressure. Data from animal and human studies suggest that these effects arise, at least in part, fr...
Saved in:
| Main Author: | Bonnie L. Blazer-Yost |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2010/785369 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARα+γ Agonists
by: Martin B. Oleksiewicz, et al.
Published: (2008-01-01) -
Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-γ Agonists
by: Catherine Gurley, et al.
Published: (2008-01-01) -
Prostaglandins as PPARγ Modulators in Adipogenesis
by: Ko Fujimori
Published: (2012-01-01) -
Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer
by: Melody Chiu, et al.
Published: (2017-01-01) -
Dietary Modulation of Inflammation-Induced Colorectal Cancer through PPARγ
by: Ashlee B. Carter, et al.
Published: (2009-01-01)